Literature DB >> 11625003

[Pasteurian science through the antirabies vaccine: the case of Mexico].

A C Rodríguez de Romo1.   

Abstract

The history of the rabies in Mexico is a versatile topic because it provides a chance to study different aspects of the history of Mexican science and medicine. This article reconstructs the sequence of events related to rabies vaccination in Mexico. History is also used as a model to study scientific transfer and scientific imperialism, the use of science by politicians in order to validate their governments, and the impact of French medicine on Mexican medicine. In 1888 the physician Eduardo Liceaga, an important political figure, brought the rabies vaccine to Mexico. President Porfirío Diaz supported Liceaga because he assumed that the vaccine was synonymous with modernity, and hence a sign of good government. We also analyze the reasons why there was no Pasteur Institute in Mexico, even though the conditions that allowed its creation in other countries also existed. Two points are of particular interest: 1) Despite its importance, this topic has not formally been studied in the context of the history of Mexican medicine, and 2) A considerable part of the present research is based on original, unpublished manuscripts in French and Mexican archives.

Mesh:

Substances:

Year:  1996        PMID: 11625003

Source DB:  PubMed          Journal:  Dynamis        ISSN: 0211-9536            Impact factor:   0.429


  2 in total

1.  The Mexican response to high altitudes in the 1890s: the case of a physician and his "magic mountain".

Authors:  Ana Cecilia Rodríguez de Romo; José Rogelio Pérez Padilla
Journal:  Med Hist       Date:  2003-10       Impact factor: 1.419

Review 2.  Successful strategies implemented towards the elimination of canine rabies in the Western Hemisphere.

Authors:  Andres Velasco-Villa; Luis E Escobar; Anthony Sanchez; Mang Shi; Daniel G Streicker; Nadia F Gallardo-Romero; Fernando Vargas-Pino; Veronica Gutierrez-Cedillo; Inger Damon; Ginny Emerson
Journal:  Antiviral Res       Date:  2017-04-04       Impact factor: 5.970

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.